Reversible posterior leukoencephalopathy syndrome and bevacizumab

N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Humans
  • Hypertension / complications
  • Hypertensive Encephalopathy / chemically induced*
  • Middle Aged
  • Rectal Neoplasms / drug therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab